Search for: "Michel v. Executive Office"
Results 41 - 60
of 190
Sort by Relevance
|
Sort by Date
9 Jun 2021, 9:34 am
Maître Audet, the Board’s General Counsel, noted some possible questions arising from the pending SCC York University v. [read post]
17 Mar 2021, 12:44 pm
That same day the court also decided in Minoru Yasui v. [read post]
31 Jan 2021, 9:54 am
” The President and First Lady Michelle Obama both used their own family experience to support the call for flexibility and to elevate the importance of supporting caretaking. [read post]
17 Dec 2020, 12:32 pm
June 26, 2020 Varricchio, J.), Judge Michele A. [read post]
16 Nov 2020, 5:01 am
” In Gravel v. [read post]
5 Nov 2020, 7:35 am
’s V 2.65% $5.3 billion deal to acquire Plaid Inc., a key player in the financial-technology space. [read post]
16 Aug 2020, 5:51 am
Court of Appeals for the Ninth Circuit recently declined to rehear en banc Fazaga v. [read post]
9 Aug 2020, 5:15 am
Nathaniel Sobel and Julia Solomon-Strauss discussed the most recent developments in the Trump v. [read post]
13 Jul 2020, 10:00 am
TestyPresident and Chief Executive Officer, Law School Admissions Council (LSAC) Richard M. [read post]
23 Jun 2020, 4:01 am
” The resolution also deplored “recent incidents of excessive use of force and other human rights violations by law enforcement officers against peaceful demonstrators defending the rights of Africans and of people of African descent. [read post]
5 Jun 2020, 3:00 am
Campaign Funds for Judges Warp Criminal Justice, Study Finds New York Times – Adam Liptak | Published: 6/1/2020 In Gideon v. [read post]
11 May 2020, 8:07 am
” As Michel Paradis wrote recently, this would be a big change. [read post]
25 Mar 2020, 10:38 am
” The clause does not define “Officer. [read post]
16 Mar 2020, 1:54 pm
E.g., SEC v. [read post]
9 Mar 2020, 1:21 pm
Biosimilar Markets [I entered in media res]· Eva Temkin, Acting Director for Policy, Office of Therapeutic Biologics and Biosimilars, CDER, FDA · Christine Simmon, Executive Director, Biosimilars Council, AAM: barriers to entry for biosimilars: exclusionary contracts, rebates, stakeholder misinformation. misinformation can include explicit and implicit, including policies such as naming conventions and the very existence of the interchangeable… [read post]
13 Jan 2020, 11:57 am
Customs and Border Protection, and Alex Eastman, the senior medical officer for operations in the DHS office of countering weapons of mass destruction. [read post]
31 Oct 2019, 5:59 am
As a career attorney in the Office of Legal Counsel (OLC), I worked closely with officials in the Department of Justice and the White House on congressional oversight requests and appropriate responses, including numerous questions of privilege. [read post]
28 Oct 2019, 1:07 pm
The task force will hear testimony from Michele Flournoy, the co-founder and managing partner of WestExec Advisors, and Jim Talent, the co-chair of the Reagan Institute Task Force. [read post]
11 Oct 2019, 3:00 am
The 2010 SpeechNow v. [read post]
1 Oct 2019, 6:26 am
Cabarrus County Probation and Parole Officer Michelle Welch began supervising defendant’s probation on 1 February 2017. [read post]
